In 1976, two years after the introduction of mandatory quality assurance in the United States healthcare system' and at a time of growing debate about the benefits of that investment,2 Charles Phelps, an American economist, wrote:
"The evidence used to justify these various regulations of quality has been, to be generous, sparse. The primary justification for many of these programs is that the present state of affairs is scandalous, so that change must lead to improvement. While not necessarily quarrelling with the premise, the conclusion is unwarranted. It therefore seems appropriate to begin to evaluate the evaluators, to develop a framework with which one could assess the gains to society from undertaking a quality assurance program of We found that current evaluation activity was quite limited, given the size of the programme, and was largely the preserve of external researchers rather than regions, purchasers, and providers themselves. There were few readily available tools or techniques for evaluation, which partly contributed to the limited level of activity. Most current evaluations were focused on medical audit, to the exclusion of clinical audit and quality assurance, and most evaluations were dominated by the provider-clinician perspective, with little or no manager, purchaser, or consumer input. There was little formal evaluation of audit programmes above provider level, such as in regions and national bodies. Despite the existence of annual planning and reporting mechanisms, there was little information about the audit programme across the NHS in England available in a consistent format which could support aggregations and comparisons. Few evaluative studies had considered the costs and benefits of audit in a way which would inform the debate on the future investment of healthcare resources in audit. Although regions were well placed to undertake and coordinate evaluations, few had done so beyond simply gathering and monitoring information in the annual planning and reporting cycle. Finally, we concluded that evaluators needed to be proactive, and do more than simply disseminate their findings through publications, if they were really to influence the future development of audit.
National evaluations
Two national evaluations of the audit programme are currently in progress: one commissioned by the Department of Health and being carried out by CASPE Research, and the other being undertaken independently by the National Audit Office.
The National Audit Office evaluation is focused on the clinical audit programme in England, Wales, and Scotland, and its primary aim is to identify the extent to which patients have benefited from the introduction of audit. To do this representatives will be visiting a selection of authorities in each country, starting in Scotland, and they will produce a separate report for each country.
CASPE Research has been commissioned by the Department of Health to undertake an evaluation of the medical audit programme in the hospital and community health services in England. The CASPE project consists of a series of separate but interlinked subprojects or research strands, each directed at a different area of the evaluation of the medical audit programme. For example, we plan to map the progress of the programme across all healthcare providers; to assess the roles and involvement of purchasers in the programme; to examine regionally and nationally based initiatives within the programme; to undertake a detailed review of the progress, impact, and costs of the programme from various perspectives; to assess the mechanisms for monitoring and reporting within the programme; to identify some models of good practice in audit; to develop some evaluative tools for use by others in evaluating audit programmes; and to examine the impact of audit programmes on provider performance.
These research strands will be served by a combination of data collection mechanisms, including postal surveys, site visits, case studies, and the use of existing data obtained from various sources. They are linked together within an overall evaluative framework developed at the beginning of the project. 6 The research strands are designed to build up into an extensive evaluation of the medical audit programme, which addresses a range of programme attributes from various perspectives and at several organizational levels.
The CASPE project is being overseen by an advisory panel, made up of representatives of the Department of Health and the Clinical Outcomes Group. We are keen to use to the full the understanding and experience of those involved in the medical audit programme, and we will be asking them to contribute by responding to surveys and hosting site visits. We plan to produce a series of evaluation reports during the project and to ensure that the audit staff, clinicians, and managers who participate in the data collection will receive copies of those reports as soon as they become available.
Conclusions
Like Charles Phelps, we believe that proper evaluation is crucial to the development of quality assurance and medical and clinical audit. Large scale projects such as the CASPE Research and National Audit Office studies have an important role, but evaluation needs to be incorporated into audit projects and programmes at every level. If audit is to become a continuing and embedded part of clinical practice it should do so on its demonstrated merits, rather than through an act of blind faith.
For more information about the CASPE Research evaluation of the medical audit programme in the hospital and community health services in England, please contact CASPE Research, 22 Palace Court, Bayswater, London W2 4HU (Tel 071 229 8739).
